Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome.

CONTEXT Hesperidin, a citrus flavonoid, and its metabolite hesperetin may have vascular actions relevant to their health benefits. Molecular and physiological mechanisms of hesperetin actions are unknown. OBJECTIVE We tested whether hesperetin stimulates production of nitric oxide (NO) from vascular endothelium and evaluated endothelial function in subjects with metabolic syndrome on oral hesperidin therapy. DESIGN, SETTING, AND INTERVENTIONS: Cellular mechanisms of action of hesperetin were evaluated in bovine aortic endothelial cells (BAEC) in primary culture. A randomized, placebo-controlled, double-blind, crossover trial examined whether oral hesperidin administration (500 mg once daily for 3 wk) improves endothelial function in individuals with metabolic syndrome (n = 24). MAIN OUTCOME MEASURE We measured the difference in brachial artery flow-mediated dilation between placebo and hesperidin treatment periods. RESULTS Treatment of BAEC with hesperetin acutely stimulated phosphorylation of Src, Akt, AMP kinase, and endothelial NO synthase to produce NO; this required generation of H(2)O(2). Increased adhesion of monocytes to BAEC and expression of vascular cell adhesion molecule-1 in response to TNF-α treatment was reduced by pretreatment with hesperetin. In the clinical study, when compared with placebo, hesperidin treatment increased flow-mediated dilation (10.26 ± 1.19 vs. 7.78 ± 0.76%; P = 0.02) and reduced concentrations of circulating inflammatory biomarkers (high-sensitivity C-reactive protein, serum amyloid A protein, soluble E-selectin). CONCLUSIONS Novel mechanisms for hesperetin action in endothelial cells inform effects of oral hesperidin treatment to improve endothelial dysfunction and reduce circulating markers of inflammation in our exploratory clinical trial. Hesperetin has vasculoprotective actions that may explain beneficial cardiovascular effects of citrus consumption.

[1]  Yumiko Iwasaki,et al.  Effects of long-term administration of hesperidin and glucosyl hesperidin to spontaneously hypertensive rats. , 2002, Journal of nutritional science and vitaminology.

[2]  D. Grobbee,et al.  Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? , 2005, Journal of the American College of Cardiology.

[3]  N. Borradaile,et al.  Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. , 2003, Diabetes.

[4]  M. Kibata,et al.  Effects of glucosyl hesperidin on serum lipids in hyperlipidemic subjects: preferential reduction in elevated serum triglyceride level. , 2004, Journal of nutritional science and vitaminology.

[5]  Gary Williamson,et al.  Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. , 2005, The American journal of clinical nutrition.

[6]  M. Quon,et al.  EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. , 2007, American journal of physiology. Endocrinology and metabolism.

[7]  J. Fernández-Real,et al.  Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.

[8]  M. Quon,et al.  Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. , 2000, Circulation.

[9]  M. Quon,et al.  Epigallocatechin Gallate, a Green Tea Polyphenol, Mediates NO-dependent Vasodilation Using Signaling Pathways in Vascular Endothelium Requiring Reactive Oxygen Species and Fyn* , 2007, Journal of Biological Chemistry.

[10]  M. Quon,et al.  Treatment of Spontaneously Hypertensive Rats With Rosiglitazone and/or Enalapril Restores Balance Between Vasodilator and Vasoconstrictor Actions of Insulin With Simultaneous Improvement in Hypertension and Insulin Resistance , 2006, Diabetes.

[11]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[12]  M. Quon,et al.  Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms , 2006, Circulation.

[13]  D Kromhout,et al.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.

[14]  A. Scuteri,et al.  Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus. , 2007, Metabolism: clinical and experimental.

[15]  C. Lugnier,et al.  Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[16]  Young‐Bae Park,et al.  Naringin Has an Antiatherogenic Effect With the Inhibition of Intercellular Adhesion Molecule-1 in Hypercholesterolemic Rabbits , 2001, Journal of cardiovascular pharmacology.

[17]  D. Purdie.  Statistical Methods in Medical Research, 4th edn , 2003 .

[18]  C. Auger,et al.  The EGCg-induced redox-sensitive activation of endothelial nitric oxide synthase and relaxation are critically dependent on hydroxyl moieties. , 2010, Biochemical and biophysical research communications.

[19]  P. Vanhoutte,et al.  Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. , 1986, The American journal of physiology.

[20]  G. Oh,et al.  Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. , 2001, Biochemical and biophysical research communications.

[21]  Seema Bhagwat,et al.  Flavonoid content of U.S. fruits, vegetables, and nuts. , 2006, Journal of agricultural and food chemistry.

[22]  M. Quon,et al.  Insulin-stimulated Activation of eNOS Is Independent of Ca2+ but Requires Phosphorylation by Akt at Ser1179 * , 2001, The Journal of Biological Chemistry.

[23]  N. Borradaile,et al.  Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin , 1999, Lipids.

[24]  D. Jacobs,et al.  Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. , 2007, The American journal of clinical nutrition.

[25]  M. Quon,et al.  Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. , 2009, Atherosclerosis.

[26]  J. Keaney,et al.  Acute EGCG Supplementation Reverses Endothelial Dysfunction in Patients with Coronary Artery Disease , 2007, Journal of the American College of Nutrition.

[27]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Circulation.

[28]  C. Lugnier,et al.  Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (+/-)-naringenin. , 2005, Planta medica.

[29]  J. Lambert,et al.  The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. , 2010, Archives of biochemistry and biophysics.

[30]  R. Muniyappa,et al.  Cardiovascular actions of insulin. , 2007, Endocrine reviews.

[31]  D. Barron,et al.  Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial. , 2006, The Journal of nutrition.

[32]  Yuguang Lin,et al.  The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. , 2010, The Journal of nutrition.

[33]  C. Napoli,et al.  Nitric oxide and atherosclerosis: an update. , 2006, Nitric oxide : biology and chemistry.

[34]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[35]  J. Lee,et al.  Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. , 2003, Clinical nutrition.

[36]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[37]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[38]  P. Dandona,et al.  Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. , 2010, The American journal of clinical nutrition.

[39]  R. Muniyappa,et al.  Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. , 2008, The American journal of clinical nutrition.

[40]  H. Chung,et al.  Modulation of the age‐related nuclear factor‐κB (NF‐κB) pathway by hesperetin , 2006, Aging cell.

[41]  J. Loscalzo,et al.  Cellular adhesion molecules and atherogenesis. , 1999, The American journal of medicine.

[42]  Hui Chen,et al.  Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium. , 2006, Molecular endocrinology.

[43]  J. Keaney,et al.  Hydrogen Peroxide Activates Endothelial Nitric-oxide Synthase through Coordinated Phosphorylation and Dephosphorylation via a Phosphoinositide 3-Kinase-dependent Signaling Pathway* , 2002, The Journal of Biological Chemistry.

[44]  V. Ferrans,et al.  Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.

[45]  J. Jordan,et al.  HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. , 2000, The American journal of clinical nutrition.

[46]  N. Borradaile,et al.  Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. , 2005, Diabetes.

[47]  Tadashi Hase,et al.  Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. , 2008, Journal of nutritional science and vitaminology.

[48]  M. Kibata,et al.  Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality. , 2005, Journal of nutritional science and vitaminology.

[49]  Ian Harvey,et al.  Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. , 2008, The American journal of clinical nutrition.

[50]  J. Zweier,et al.  Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts , 1997, Science.

[51]  P. Ortiz de Montellano,et al.  AMP‐activated protein kinase phosphorylation of endothelial NO synthase , 1999, FEBS letters.

[52]  Li Liu,et al.  Distinct effects of naringenin and hesperetin on nitric oxide production from endothelial cells. , 2008, Journal of agricultural and food chemistry.

[53]  Gary Williamson,et al.  Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. , 2005, The American journal of clinical nutrition.